Max Healthcare Institute Crescita futura
Future criteri di controllo 5/6
Max Healthcare Institute prevede che gli utili e i ricavi cresceranno rispettivamente di 29.5% e 25.9% all'anno. Si prevede che l'EPS crescerà di 29% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 16.6% in 3 anni.
Informazioni chiave
29.5%
Tasso di crescita degli utili
29.0%
Tasso di crescita dell'EPS
| Healthcare crescita degli utili | 26.5% |
| Tasso di crescita dei ricavi | 25.9% |
| Rendimento futuro del capitale proprio | 16.6% |
| Copertura analitica | Good |
| Ultimo aggiornamento | 17 Oct 2024 |
Aggiornamenti recenti sulla crescita futura
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Recent updates
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now
Sep 14Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Jul 18Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark
Jun 21Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 3/31/2027 | 119,226 | 23,298 | 14,064 | 26,434 | 13 |
| 3/31/2026 | 101,954 | 19,814 | 8,484 | 22,603 | 19 |
| 3/31/2025 | 80,110 | 14,969 | 6,747 | 18,246 | 19 |
| 9/30/2024 | 59,970 | 10,590 | 2,649 | 13,125 | N/A |
| 6/30/2024 | 56,640 | 10,538 | N/A | N/A | N/A |
| 3/31/2024 | 54,060 | 10,576 | 3,359 | 11,218 | N/A |
| 12/31/2023 | 51,976 | 10,570 | N/A | N/A | N/A |
| 9/30/2023 | 50,044 | 9,901 | 7,141 | 11,564 | N/A |
| 6/30/2023 | 47,807 | 11,708 | N/A | N/A | N/A |
| 3/31/2023 | 45,626 | 11,035 | 9,485 | 12,841 | N/A |
| 12/31/2022 | 42,799 | 9,763 | N/A | N/A | N/A |
| 9/30/2022 | 41,143 | 9,437 | 3,873 | 9,507 | N/A |
| 6/30/2022 | 39,976 | 6,310 | N/A | N/A | N/A |
| 3/31/2022 | 39,366 | 6,051 | 1,872 | 7,405 | N/A |
| 12/31/2021 | 37,978 | 5,510 | N/A | N/A | N/A |
| 9/30/2021 | 36,193 | 4,516 | 1,486 | 3,086 | N/A |
| 6/30/2021 | 32,486 | 3,236 | N/A | N/A | N/A |
| 3/31/2021 | 25,080 | -1,375 | -6 | 1,179 | N/A |
| 12/31/2020 | 27,772 | -1,177 | N/A | N/A | N/A |
| 9/30/2020 | 22,487 | -2,134 | 3,024 | 3,911 | N/A |
| 6/30/2020 | 14,849 | -2,681 | N/A | N/A | N/A |
| 3/31/2020 | 10,590 | 590 | -130 | 771 | N/A |
| 12/31/2019 | 10,081 | 268 | N/A | N/A | N/A |
| 9/30/2019 | 18,609 | 720 | N/A | N/A | N/A |
| 6/30/2019 | 17,719 | 360 | N/A | N/A | N/A |
| 3/31/2019 | 16,939 | -30 | -268 | 890 | N/A |
| 6/30/2018 | 17,053 | -704 | N/A | N/A | N/A |
| 3/31/2018 | 17,303 | -302 | N/A | 822 | N/A |
| 3/31/2017 | 16,085 | -14 | N/A | 1,561 | N/A |
| 3/31/2016 | 14,343 | -180 | N/A | 7,225 | N/A |
| 3/31/2015 | 7,896 | -381 | N/A | 387 | N/A |
| 3/31/2014 | 9,445 | -646 | N/A | 732 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di MAXHEALTH ( 29.5% all'anno) è superiore al tasso di risparmio ( 6.7% ).
Guadagni vs Mercato: Si prevede che gli utili di MAXHEALTH ( 29.5% all'anno) cresceranno più rapidamente del mercato Indian ( 17.9% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di MAXHEALTH cresceranno in modo significativo nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di MAXHEALTH ( 25.9% all'anno) crescerà più rapidamente del mercato Indian ( 10.2% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di MAXHEALTH ( 25.9% all'anno) crescerà più rapidamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di MAXHEALTH sarà basso tra 3 anni ( 16.6 %).